Navigation Links
Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors
Date:7/12/2013

New York, NY (PRWEB) July 12, 2013

On July 12, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Shelli Kesler, a Stanford University clinical neuropsychologist, and her colleagues for using brain-training software to help lift the mental fog caused by cancer treatment.

According to a July 2nd, 2013 Medcitynews.com article entitled “Brain-training software may help lift ‘chemo fog’ cause by cancer treatment,” “Chemo fog” is a mental fuzziness induced by repeated cancer treatment. Researchers say cognitive brain exercises can improve brain function and ease the effects of the recurring chemotherapy.

Researchers went on to say that “those who used a brain-training program for 12 weeks were more cognitively flexible, more verbally fluent, and faster-thinking than survivors who didn’t train."

Shelli Kesler, the Stanford University clinical neuropsychologist who led the research, says patients who endure repeated chemotherapy treatments for cancer do show changes in brain structure and function and often have long-term cognitive effects. The new study suggests “cognitive training could be one possible avenue for helping to improve cognitive function in cancer survivors treated with chemotherapy.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, sees this brain training software as a great tool for cancer survivors. He says “This possible alternative to post-chemotherapy treatment could be a great way for survivors to feel 100 percent better, mentally. The physical effects are obvious but these mental effects can sometimes be hard to detect. Hopefully this brain-training could potentially become an effective way to help survivors on their road to recovery.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations

#####

Read the full story at http://www.prweb.com/releases/braincancer/research/prweb10909936.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Comments on Discovery of a Cause of Resistance to Therapy in Cases of Brain Cancer
2. Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
3. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
4. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
5. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
6. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
7. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
8. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
9. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
10. Avatar therapy helps silence voices in schizophrenia
11. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: